29Jan/100
Herceptin Again Proves Mettle Against Breast Cancer (HealthDay)
HealthDay - THURSDAY, Jan. 28 (HealthDay News) -- High-risk breast cancer
patients with HER2-positive tumors benefit from receiving the targeted
therapy Herceptin while undergoing chemotherapy, new research shows.